Diagnostic and prognostic potential of presepsin in Emergency Department patients presenting with systemic inflammatory response syndrome

Journal of Infection

Volumn 69, Issue 6, 2014, Pages 627-630

  Rabensteiner, Jasmin ^a   Skvarc, Miha ^b   Hoenigl, Martin ^a,c   Osredkar, Josko ^d   Prueller, Florian ^a   Reichsoellner, Matthias ^a   Krause, Robert ^a   Raggam, Reinhard B ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; PRESEPSIN; PROCALCITONIN; UNCLASSIFIED DRUG;

ADULT; AGED; AUSTRIA; BACTERIUM CULTURE; BLOOD CULTURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EMERGENCY WARD; ESCHERICHIA COLI; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; STAPHYLOCOCCUS AUREUS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; BACTERIAL INFECTIONS; MICROBIOLOGY; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

BACTERIAL INFECTIONS; FEMALE; HUMANS; MALE; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

EID: 84922826659     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.07.024     Document Type: Letter

References (9)

1. ten Oever J., Tromp M., Bleeker-Rovers C.P., Joosten L.A., Netea M.G., Pickkers P., et al. Combination of biomarkers for the discrimination between bacterial and viral lower respiratory tract infections. J Infect 2012 Dec, 65(6):490-495.
2. Hoenigl M., Raggam R.B., Wagner J., Valentin T., Leitner E., Seeber K., et al. Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome. Clin Biochem 2013 Feb, 46(3):225-229.
3. Raggam R.B., Wagner J., Pruller F., Grisold A., Leitner E., Zollner-Schwetz I., et al. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome. J Intern Med 2014 Mar 19, http://dx.doi.org/10.1111/joim.12238. [Epub ahead of print].
4. Hoenigl M., Raggam R.B., Wagner J., Prueller F., Grisold A.J., Leitner E., et al. Procalcitonin fails to predict bacteremia in SIRS patients: a cohort study. Int J Clin Pract 2014 Jun 4, http://dx.doi.org/10.1111/ijcp.12474. [Epub ahead of print].
5. Okamura Y., Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin Chim Acta 2011 Nov 20, 412(23-24):2157-2161.
6. Ulla M., Pizzolato E., Lucchiari M., Loiacono M., Soardo F., Forno D., et al. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study. Crit Care 2013 Jul 30, 17(4):R168.
7. Romualdo L.G., Torrella P.E., Gonzalez M.V., Sanchez R.J., Holgado A.H., Freire A.O., et al. Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department. Clin Biochem 2014 May, 47(7-8):505-508.
8. Pizzolato E., Ulla M., Galluzzo C., Lucchiari M., Manetta T., Lupia E., et al. Role of presepsin for the evaluation of sepsis in the emergency department. Clin Chem Lab Med 2014 Jun4, pii: /j/cclm.ahead-of-print/cclm-2014-0199/cclm-2014-0199.xml. http://dx.doi.org/10.1515/cclm-2014-0199. [Epub ahead of print].
9. Masson S., Caironi P., Spanuth E., Thomae R., Panigada M., Sangiorgi G., et al. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial. Crit Care 2014 Jan 7, 18(2):R6.